Travis Alvin Thompson - 22 Jun 2023 Form 3 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Role
Chief Accounting Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
BCYC
Transactions as of
22 Jun 2023
Net transactions value
$0
Form type
3
Filing time
03 Jul 2023, 17:11:04 UTC
Next filing
06 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BCYC Ordinary Shares 8,094 22 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCYC Employee Stock Option (right to buy) 22 Jun 2023 Ordinary Shares 3,929 $1.83 Direct F2, F3
holding BCYC Employee Stock Option (right to buy) 22 Jun 2023 Ordinary Shares 456 $8.03 Direct F2, F3
holding BCYC Employee Stock Option (right to buy) 22 Jun 2023 Ordinary Shares 14,063 $9.82 Direct F4
holding BCYC Employee Stock Option (right to buy) 22 Jun 2023 Ordinary Shares 23,500 $17.95 Direct F5
holding BCYC Employee Stock Option (right to buy) 22 Jun 2023 Ordinary Shares 9,000 $60.87 Direct F6
holding BCYC Employee Stock Option (right to buy) 22 Jun 2023 Ordinary Shares 40,000 $29.60 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit ("RSU") awards. 3,094 RSUs shall vest in eleven equal quarterly installments commencing on July 3, 2023. 5,000 RSUs shall vest one-fourth (1/4) of the total number of RSUs on January 3, 2024, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.
F2 Fully vested and exercisable.
F3 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.2605 to GBP 1.00 as of May 22, 2019.
F4 This option vested one-fourth (1/4) of the total number of shares on January 2, 2021, and the remaining shares vested or shall vest in 36 equal monthly installments at the end of each calendar month thereafter.
F5 This option vested one-fourth (1/4) of the total number of shares on January 4, 2022, and the remaining shares vested or shall vest in 36 equal monthly installments thereafter.
F6 This option vested one-fourth (1/4) of the total number of shares on January 3, 2023, and the remaining shares vested or shall vest in 36 equal monthly installments thereafter.
F7 This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 3, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney